港股早評:三大指數小幅低開 石油股走低 東方甄選開升近3%
隔夜美股三大指數收跌,中概指數升0.66%。港股三大指數小幅低開,恒指跌0.12%,國指跌0.14%,恒生科技指數跌0.09%。盤面上,大型科技股升跌不一,其中,阿里巴巴升近2%,快手升1.3%,百度升1%,騰訊小幅上升,小米、美團飄綠;國際油價下跌,石油股走低,中國石油化工跌超2%;昨日走強的濠賭股普跌,新濠國際發展跌近6%,創新藥概念股部分下跌,百濟神州、諾誠健華、三生製藥、藥明康德均有跌幅,腦機概念股南京熊貓電子跌近5%。另一方面,軟件類股、直播概念股、內房股與物管股多數上升,東方甄選升近3%。(格隆匯)
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.